Prävalenz potentieller Arzneimittelinteraktionen bei ambulanten Patienten unter Statin-Therapie

Abstract

Drug combinations with potentially severe DDIs are common in patients treated with statins due to pharmacotherapy of their co-morbidities. Special attention in this specific population should be drawn on patients with polypharmacy and those with drug treatments for arrhythmia or heart failure.